{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:40:13Z","timestamp":1707439213024},"reference-count":33,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,25]],"date-time":"2014-04-25T00:00:00Z","timestamp":1398384000000},"content-version":"vor","delay-in-days":2702,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atenci\u00f3n Primaria"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1157\/13095927","type":"journal-article","created":{"date-parts":[[2006,12,14]],"date-time":"2006-12-14T16:33:03Z","timestamp":1166113983000},"page":"555-562","source":"Crossref","is-referenced-by-count":2,"title":["\u00bfSiete o diez d\u00edas? Estudio de coste-efectividad sobre la duraci\u00f3n del tratamiento de la infecci\u00f3n por H. pylori en atenci\u00f3n primaria"],"prefix":"10.1016","volume":"38","author":[{"given":"Emili","family":"Gen\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Calvet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Azagra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier P.","family":"Gisbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13095927_bib1","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0140-6736(84)91816-6","article-title":"Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration","volume":"1","author":"Marshall","year":"1984","journal-title":"Lancet"},{"key":"10.1157\/13095927_bib2","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0140-6736(94)91111-8","article-title":"Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up","volume":"343","author":"Forbes","year":"1994","journal-title":"Lancet"},{"key":"10.1157\/13095927_bib3","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1365-2036.2004.01898.x","article-title":"Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer","volume":"19","author":"Gisbert","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1157\/13095927_bib4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0212-6567(00)78526-X","article-title":"Beneficios del tratamiento erradicador de la infecci\u00f3n por Helicobacter pylori en pacientes ulcerosos en un centro de atenci\u00f3n primaria","volume":"25","author":"Azagra","year":"2000","journal-title":"Aten Primaria"},{"key":"10.1157\/13095927_bib5","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1001\/archinte.158.8.852","article-title":"Cost savings in duodenal ulcer therapy through Helicobacter pylori eradication compared with conventional therapies: results of a randomized, double-blind, multicenter trial Gastrointestinal Utilization Trial Study Group","volume":"158","author":"Sonnenberg","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1157\/13095927_bib6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1157\/13078424","article-title":"Tratamiento erradicador de Helicobacter pylori. Recomendaciones de la II Conferencia Espa\u00f1ola de Consenso","volume":"125","author":"Gisbert","year":"2005","journal-title":"Med Clin (Barc)"},{"key":"10.1157\/13095927_bib7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1365-2036.2002.01169.x","article-title":"Current concepts in the management of Helicobacter pylori infection: the Maastricht 2-2000 Consensus Report","volume":"16","author":"Malfertheiner","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1157\/13095927_bib8","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1111\/j.1572-0241.1998.00684.x","article-title":"Guidelines for the management of Helicobacter pylori infection. Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology","volume":"93","author":"Howden","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13095927_bib9","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1046\/j.1365-2036.2000.00744.x","article-title":"A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxicillin for treating Helicobacter pylori infection","volume":"14","author":"Calvet","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1157\/13095927_bib10","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1046\/j.1365-2036.2001.01031.x","article-title":"What is the optimal length of proton pump inhibitor-based triple therapies for H. pylori?A cost-effectiveness analysis","volume":"15","author":"Calvet","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1157\/13095927_bib11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0025-7753(00)71326-1","article-title":"Efectividad de la combinaci\u00f3n de omeprazol, claritromicina y amoxicilina en la erradicaci\u00f3n de Helicobacter pylori en pacientes con ulcus p\u00e9ptico activo: resultados preliminares del Estudio GEHPY","volume":"114","author":"Ba\u00f1os","year":"2000","journal-title":"Med Clin (Barc)"},{"key":"10.1157\/13095927_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0025-7753(01)71738-1","article-title":"Resistencia de Helicobacter pylori al metronidazol y a la claritromicina en Espa\u00f1a. Una revisi\u00f3n sistem\u00e1tica","volume":"116","author":"Gisbert","year":"2001","journal-title":"Med Clin (Barc)"},{"key":"10.1157\/13095927_bib13","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1111\/j.1572-0241.2005.50019.x","article-title":"Seven vs ten-day of rabeprazole triple therapy for Helicobacter pylori eradication: a multicenter randomized trial","volume":"100","author":"Calvet","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13095927_bib14","first-page":"1383","article-title":"Are twelve days of omeprazole,amoxicillin and clarithromycin better than six days for treating H.pylori infection in peptic ulcer and in non-ulcer dyspepsia?","volume":"48","author":"Gisbert","year":"2001","journal-title":"Hepatogastroenterology"},{"key":"10.1157\/13095927_bib15","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1097\/00042737-200012120-00003","article-title":"Scoring system has better discriminative value than Helicobacter pylori testing in patients with dyspepsia in a setting with high prevalence of infection","volume":"12","author":"Barenys","year":"2000","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1157\/13095927_bib16","unstructured":"Diari Oficial de la Generalitat de Catalunya No. 3736 OS32S3c2A5AfUh. Electronic citation. 2004. 24-11-2004. 17."},{"key":"10.1157\/13095927_bib17","first-page":"547","article-title":"Eficacia de una terapia secuencial en la erradicaci\u00f3n deHelicobacter pylori: cu\u00e1druple terapia con omeprazol, metronidazol,tetraciclina y bismuto tras el fracaso de la combinaci\u00f3n de omeprazol, claritromicina y amoxicilina","volume":"22","author":"Baena D\u00edez","year":"1998","journal-title":"Aten Primaria"},{"key":"10.1157\/13095927_bib18","first-page":"224","article-title":"[13C]urea breath test to confirm eradication of Helicobacter pylori","volume":"90","author":"Slomianski","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13095927_bib19","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/S0016-5085(97)70024-6","article-title":"Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis","volume":"112","author":"Labenz","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1157\/13095927_bib20","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1053\/gast.1996.v110.pm8613015","article-title":"Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review","volume":"110","author":"Hopkins","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1157\/13095927_bib21","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1080\/00365529850172485","article-title":"Recurrence of Helicobacter pylori infection after eradication: incidence and variables influencing it","volume":"33","author":"Gisbert","year":"1998","journal-title":"Scand J Gastroenterol"},{"key":"10.1157\/13095927_bib22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0002-9343(99)00196-5","article-title":"Symptom status and the desire for Helicobacter pylori confirmatory testing after eradication therapy in patients with peptic ulcer disease","volume":"107","author":"Fendrick","year":"1999","journal-title":"Am J Med"},{"key":"10.1157\/13095927_bib23","first-page":"1381","article-title":"90% cure: which anti-Helicobacter therapy can achieve this treatment goal?","volume":"90","author":"De Boer","year":"1995","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 1","key":"10.1157\/13095927_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2036.1995.tb00779.x","article-title":"The role of proton pump inhibitors in the treatment of gastro-oesophageal reflux disease","volume":"9","author":"Bardhan","year":"1995","journal-title":"Aliment Pharmacol Ther"},{"issue":"Supl 3","key":"10.1157\/13095927_bib25","first-page":"46","article-title":"Impacto econ\u00f3mico de los efectos secundarios gastrointestinales asociados a antinflamatorios no esteroides en el Servicio Nacional de Salud","volume":"114","author":"Lanas","year":"2000","journal-title":"Med Clin (Barc)"},{"key":"10.1157\/13095927_bib26","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1080\/003655299750025822","article-title":"Helicobacter pylori test-and-treat\u2019 strategy for dyspeptic patients","volume":"34","author":"Gisbert","year":"1999","journal-title":"Scand J Gastroenterol"},{"key":"10.1157\/13095927_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00042737-199701000-00002","article-title":"Current European concepts in the management of Helicobacter pylori infection: the Maastricht Consensus Report. The European Helicobacter pylori Study Group (EHPSG)","volume":"9","author":"Malfertheiner","year":"1997","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1157\/13095927_bib28","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/bmj.324.7344.999","article-title":"Randomised trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H pylori testing alone in the management of dyspepsia","volume":"324","author":"McColl","year":"2002","journal-title":"BMJ"},{"key":"10.1157\/13095927_bib29","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/bmj.324.7344.1012","article-title":"Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADETHp)randomised controlled trial","volume":"324","author":"Chiba","year":"2002","journal-title":"BMJ"},{"key":"10.1157\/13095927_bib30","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0212-6567(02)70618-5","article-title":"Manejo de la dispepsia, la enfermedad ulcerosa y la infecci\u00f3n por Helicobacter pylori en atenci\u00f3n primaria","volume":"29","author":"Gen\u00e9","year":"2002","journal-title":"Aten Primaria"},{"key":"10.1157\/13095927_bib31","first-page":"473","article-title":"Actitud de los m\u00e9dicos de atenci\u00f3n primaria del \u00e1rea metropolitana de Barcelona frente al diagn\u00f3stico y tratamiento de la infecci\u00f3n por Helicobacter pylori en enfermedades gastroduodenales","volume":"21","author":"Mart\u00ednez-S\u00e1nchez","year":"1998","journal-title":"Gastroenterol Hepatol"},{"key":"10.1157\/13095927_bib32","unstructured":"Grupos terap\u00e9uticos y principios activos de mayor consumo en el Sistema Nacional de Salud durante 2001. Informaci\u00f3n Terap\u00e9utica. 2002;26:78-83."},{"key":"10.1157\/13095927_bib33","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1046\/j.1365-2036.2003.01450.x","article-title":"Systematic review:Rabeprazole-based therapies in Helicobacter pylori eradication","volume":"17","author":"Gisbert","year":"2003","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Atenci\u00f3n Primaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656706705777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212656706705777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:11:57Z","timestamp":1707437517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0212656706705777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S0212656706705777"],"URL":"https:\/\/doi.org\/10.1157\/13095927","relation":{},"ISSN":["0212-6567"],"issn-type":[{"value":"0212-6567","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}